ProUroCare Medical Inc. Amends the Maturity Date of its $900,000 Promissory Note with Crown Bank; Announces Management Changes
The company also announced that current director Dr. Michael Chambers, JD, Ph.D., has been named Chairman of its Board of Directors. Dr. Chambers is an experienced businessman, entrepreneur and attorney. Dr. Chambers currently serves as President and CEO of Swift Biotechnology. Dr. Chambers also serves on the corporate boards of InqBio Systems, Gene Capture and BioAlabama. Dr. Chambers assumes the Chairmanship role from Rick Carlson, company's CEO, who will continue to serve as CEO and Director.